KCNA3 and ischemia: Previous work has shown that pharmacological inhibitors of Kv1 channels (4-aminopyridine or correolide) or genetic deletion of pore proteins that assemble Kv1 channels (Kv1.5 or Kv1.3) dissociate changes in blood flow from metabolism, resulting in ischemia and cardiac pump dysfunction8,9,26.